Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01845857 · ClinicalTrials.gov registry record · NA
A National Study of the Chronic Disease Self-Management Program
A NA study of Diabetes Mellitus, Type 2 and Chronic Disease, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,170
- Enrollment target
- 1
- Study location
NCT01845857 is a NA study of Diabetes Mellitus, Type 2 and Chronic Disease that has completed, run by Stanford University. The registered enrollment target is 1,170 participants, below the 4,482-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01845857, a NA study of Diabetes Mellitus, Type 2 and Chronic Disease, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,170 participants
- Enrollment target
- 1
- Study location
Study Summary
This survey will address important research, practice, and policy questions: How does Chronic Disease Self-Management Program (CDSMP) impact participants' general health, their health behaviors, and their need for health care utilization? Who benefits most from the CDSMP program? Are predicted gains maintained over a six and twelve month period? Can critical clinical changes be seen for those who are diabetic?
Conditions Studied
Interventions
- BEHAVIORAL Chronic Disease Self-Management Workshop
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,170 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01845857
The ClinicalTrials.gov registry entry for NCT01845857 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,170 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,482-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (74% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Chronic Disease Self-Management Workshop is the first listed.
NCT01845857 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01845857 about?
NCT01845857 is a clinical study titled "A National Study of the Chronic Disease Self-Management Program". This survey will address important research, practice, and policy questions: How does Chronic Disease Self-Management Program (CDSMP) impact participants' general health, their health behaviors, and their need for health care utilization? Who benefits most from the CDSMP program? Are predicted gains...
What is the current status of trial NCT01845857?
This trial is currently completed. It is a NA study. The enrollment target is 1,170 participants. The study started on 2010-08. Estimated completion is 2013-04.
What conditions does trial NCT01845857 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Chronic Disease.
What interventions are being tested in trial NCT01845857?
The interventions under investigation include: Chronic Disease Self-Management Workshop (BEHAVIORAL).
Who is sponsoring clinical trial NCT01845857?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01845857 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.